Global Genitourinary Drugs Market Research Report 2015-2025

HEY3843876
79 Pages
May 2020
Healthcare

Download Sample Get Discount

Summary

The global Genitourinary Drugs market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:

Urologicals

Hormonal Therapy

Gynecological

Anti-infectives

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:

Novartis AG

Genentech

Based on Application, the report describes major application share of regional market. Application mentioned as follows:

Prostate Cancer

Ovarian Cancer

Bladder Cancer

Cervical Cancer

Renal Cancer

Erectile Dysfunction

Urinary Tract Infections

Urinary Incontinence & Overactive Bladder

Sexually Transmitted Diseases

Interstitial Cystitis

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:

Asia-Pacific

North America

Europe

South America

Middle East & Africa

Table of Contents

1 Market Overview

1.1 Objectives of Research

1.1.1 Definition

Figure Genitourinary Drugs Picture

1.1.2 Specifications

Table Product Specifications of Genitourinary Drugs

1.2 Market Segment

1.2.1 by Type

Table Products Segment of Genitourinary Drugs

Table Global Genitourinary Drugs Market by Type, 2011-2022 (USD Million)

1.2.1.1 Urologicals

Table Urologicals Overview

1.2.1.2 Hormonal Therapy

Table Hormonal Therapy Overview

1.2.1.3 Gynecological

Table Gynecological Overview

1.2.1.4 Anti-infectives

Table Anti-infectives Overview

1.2.2 by Application

Table Application Segment of Genitourinary Drugs

Table Global Genitourinary Drugs Market by Application, 2011-2022 (USD Million)

1.2.2.1 Prostate Cancer

Table Prostate Cancer Overview

1.2.2.2 Ovarian Cancer

Table Ovarian Cancer Overview

1.2.2.3 Bladder Cancer

Table Bladder Cancer Overview

1.2.2.4 Cervical Cancer

Table Cervical Cancer Overview

1.2.2.5 Renal Cancer

Table Renal Cancer Overview

1.2.2.6 Erectile Dysfunction

Table Erectile Dysfunction Overview

1.2.2.7 Urinary Tract Infections

Table Urinary Tract Infections Overview

1.2.2.8 Urinary Incontinence & Overactive Bladder

Table Urinary Incontinence & Overactive Bladder Overview

1.2.2.9 Sexually Transmitted Diseases

Table Sexually Transmitted Diseases Overview

1.2.2.10 Interstitial Cystitis

Table Interstitial Cystitis Overview

1.2.3 by Regions

Table Global Genitourinary Drugs Market by Region, 2011-2022 (USD Million)

2 Industry Chain

2.1 Industry Chain Structure

Figure Industry Chain Structure of Genitourinary Drugs

2.2 Upstream

Table Cost of Genitourinary Drugs

Figure Manufacturing Process of Genitourinary Drugs

2.3 Market

2.3.1 SWOT

Figure SWOT of Genitourinary Drugs

2.3.2 Dynamics

Table Market Dynamics

3 Environmental Analysis

3.1 Policy

Table Policy of Genitourinary Drugs

3.2 Economic

Table GDP of Major Countries

3.3 Technology

Table Technology of Genitourinary Drugs

3.4 Market Entry

Table Market Entry of Genitourinary Drugs

4 Market Segmentation by Type

4.1 Market Size

4.1.1 Urologicals Market, 2013-2018

Figure Urologicals Market Size and Growth, 2015-2019 (USD Million)

Figure Urologicals Market Size and Growth, 2015-2019 (in Volume)

Table Urologicals CAGR by Revenue and Volume, 2015-2019

4.1.2 Hormonal Therapy Market, 2013-2018

Figure Hormonal Therapy Market Size and Growth, 2015-2019 (USD Million)

Figure Hormonal Therapy Market Size and Growth, 2015-2019 (in Volume)

Table Hormonal Therapy CAGR by Revenue and Volume, 2015-2019

4.1.3 Gynecological Market, 2013-2018

Figure Gynecological Market Size and Growth, 2015-2019 (USD Million)

Figure Gynecological Market Size and Growth, 2015-2019 (in Volume)

Table Gynecological CAGR by Revenue and Volume, 2015-2019

4.1.4 Anti-infectives Market, 2013-2018

Figure Anti-infectives Market Size and Growth, 2015-2019 (USD Million)

Figure Anti-infectives Market Size and Growth, 2015-2019 (in Volume)

Table Anti-infectives CAGR by Revenue and Volume, 2015-2019

4.2 Market Forecast

4.2.1 Urologicals Market Forecast, 2020-2025

Figure Urologicals Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Urologicals Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Urologicals CAGR by Revenue and Volume, 2012-2024

4.2.2 Hormonal Therapy Market Forecast, 2020-2025

Figure Hormonal Therapy Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Hormonal Therapy Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Hormonal Therapy CAGR by Revenue and Volume, 2012-2024

4.2.3 Gynecological Market Forecast, 2020-2025

Figure Gynecological Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Gynecological Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Gynecological CAGR by Revenue and Volume, 2012-2024

4.2.4 Anti-infectives Market Forecast, 2020-2025

Figure Anti-infectives Market Estimates and Forecasts, 2020-2025 (USD Million)

Figure Anti-infectives Market Estimates and Forecasts, 2020-2025 (in Volume)

Table Anti-infectives CAGR by Revenue and Volume, 2012-2024

5 Market Segmentation by Application

5.1 Market Size

5.1.1 Prostate Cancer Market, 2013-2018

Figure Prostate Cancer Market Size and Growth, 2015-2019 (USD Million)